Social News XYZ     

Zydus hypertension drug gets US regulatory nod

Posted By: Doraiah Vundavally September 23, 2017

Zydus hypertension drug gets US regulatory nodAhmedabad, Sep 23 (IANS) Global healthcare provider Zydus Cadila on Saturday said it received approval from the US Federal Drug Authority (USFDA) to market Amlodipine and Olmesartan Medoxomil tablets for the treatment of hypertension.

"The drug, meant for treating hypertension or to lower blood pressure with other anti-hypertensive agents, will be manufactured at our group's formulations manufacturing facility at the Pharma SEZ in Ahmedabad," said the company in a regulatory filing to the BSE.

The company also received the federal regulatory approval on September 21 to market its Itraconazole capsules to treat fungal infections.

 

(This story has not been edited by Social News XYZ staff and is auto-generated from a syndicated feed.)

Facebook Comments
Zydus hypertension drug gets US regulatory nod

About VDC

Doraiah Chowdary Vundavally is a Software engineer at VTech . He is the news editor of SocialNews.XYZ and Freelance writer-contributes Telugu and English Columns on Films, Politics, and Gossips. He is the primary contributor for South Cinema Section of SocialNews.XYZ. His mission is to help to develop SocialNews.XYZ into a News website that has no bias or judgement towards any.